We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.8B
AUM Growth
-$20.8M
Cap. Flow
+$57.1M
Cap. Flow %
3.18%
Top 10 Hldgs %
23.87%
Holding
255
New
12
Increased
107
Reduced
96
Closed
12

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$28M
2
UPWK icon
Upwork
UPWK
+$20.6M
3
G icon
Genpact
G
+$18.4M
4
FOUR icon
Shift4
FOUR
+$10.2M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Sector Composition

Rank Sector Weight
1 Healthcare 31.73%
2 Technology 29.93%
3 Industrials 16.4%
4 Consumer Discretionary 7.95%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWC icon
251
iShares Micro-Cap ETF
IWC
$1.45B
-28,750
Closed -$4.53M
IWM icon
252
iShares Russell 2000 ETF
IWM
$79.8B
-17,402
Closed -$4.28M
PLRX icon
253
Pliant Therapeutics
PLRX
$66.9M
-147,705
Closed -$180K
SBUX icon
254
Starbucks
SBUX
$120B
-2,424
Closed -$204K
SNWV
255
SANUWAVE Health Inc
SNWV
$53.1M
-25,156
Closed -$751K

Similar funds

Rice Hall James & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Rice Hall James & Associates held 255 positions worth $1.8B, down 1.1% from $1.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates deployed $57.1M of net new capital in Q1 2026, opening 12 new positions and adding to 107 existing holdings. Its largest new stake was Upwork: 1,308,167 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $39.3M trimmed.

  • Rice Hall James & Associates's largest Q1 2026 buy was Upwork: 1,308,167 shares worth $14.3M.
  • Rice Hall James & Associates added most to GoDaddy in Q1 2026, an estimated $28M increase.
  • Rice Hall James & Associates's biggest Q1 2026 reduction was Amicus Therapeutics, cutting an estimated $39.3M.
  • Rice Hall James & Associates fully exited iShares Micro-Cap ETF in Q1 2026, selling an estimated $4.53M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.8B portfolio in Q1 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 12 in Q1 2026.
  • Rice Hall James & Associates's portfolio value fell 1.1% quarter-over-quarter to $1.8B.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.